CABHI Ventures

Toronto, Ontario
EarlyEst. US$36MThe 50: Canadian VC Ecosystem Guide 2026

Investment Thesis

CABHI Ventures invests in early-stage companies advancing healthy aging, brain health, and dementia care through clinically-validated breakthrough innovation. Portfolio companies gain unparalleled access to Baycrest's world-class neuroscientists, clinicians, 150+ trial site network, and real-world testing infrastructure to accelerate solutions that enhance independence, safety, cognitive health, and caregiver support.

Focus Areas

Investment Stage
Early
Sectors

Investment Signals

Check SizeC$500K
GeographyCanada-focused
ProvincesON
RoleBoth
Revenue Stagepre-revenue ok
Impact MandateYes
Business ModelsB2B, B2C, SaaS, hardware, deep-tech

Sample Portfolio Companies

Xandar Kardian

Management Team

M
Mel Barsky
J
James Mayer

What Makes Us Unique

Unparalleled access to CABHI infrastructure, Baycrest, Rotman Research Institute. World-class neuroscientists and clinicians. 150+ trial site network. Proven exits and unicorn-stage companies.

AUM & Sources

Est. US$36M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →

Similar Funds

See incorrect information?

Help us keep this directory accurate and up to date.